raxibacumab

From Aaushi
Jump to navigation Jump to search
[1]

Indications

  • treatment & prevention of inhalational anthrax (investigational)

Dosage

40 mg/kg

Adverse effects

Mechanism of action

More general terms

References

  1. ↑ Migone T-S et al Raxibacumab for the treatment of inhalational anthrax. N Engl J Med 2009 Jul 9; 361:135. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19587338
    Nabel GJ. Protecting against future shock - Inhalational anthrax. N Engl J Med 2009 Jul 9; 361:191. PMID: https://www.ncbi.nlm.nih.gov/pubmed/19587345
Retrieved from "https://aaushi.info/w/index.php?title=A323232&oldid=1172436"